Treatment trials in ankylosing spondylitis: current and future considerations.
about
A history of the term "DMARD".Nasal Crohn's disease /apheresisWhich patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.
P2860
Treatment trials in ankylosing spondylitis: current and future considerations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment trials in ankylosing spondylitis: current and future considerations.
@ast
Treatment trials in ankylosing spondylitis: current and future considerations.
@en
Treatment trials in ankylosing spondylitis: current and future considerations.
@nl
type
label
Treatment trials in ankylosing spondylitis: current and future considerations.
@ast
Treatment trials in ankylosing spondylitis: current and future considerations.
@en
Treatment trials in ankylosing spondylitis: current and future considerations.
@nl
prefLabel
Treatment trials in ankylosing spondylitis: current and future considerations.
@ast
Treatment trials in ankylosing spondylitis: current and future considerations.
@en
Treatment trials in ankylosing spondylitis: current and future considerations.
@nl
P2093
P2860
P1476
Treatment trials in ankylosing spondylitis: current and future considerations
@en
P2093
P2860
P304
P356
10.1136/ARD.61.SUPPL_3.III24
P407
P478
61 Suppl 3
P577
2002-12-01T00:00:00Z